Abstract OT-28-02: Phase II Randomized Trial of Neoadjuvant Trastuzumab and Pertuzumab with Either Palbociclib Plus Letrozole or Paclitaxel for Postmenopausal Women with Estrogen Receptor-Positive / HER2-positive Breast Cancer - the TOUCH Trial
Cancer Research（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined